Setting expectations for transcatheter mitral valve replacement in the real world
- PMID: 35434899
- DOI: 10.1002/ejhf.2506
Setting expectations for transcatheter mitral valve replacement in the real world
Comment on
-
Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experience.Eur J Heart Fail. 2022 May;24(5):899-907. doi: 10.1002/ejhf.2434. Epub 2022 Feb 10. Eur J Heart Fail. 2022. PMID: 35064722
References
-
- Muller DWM, Farivar RS, Jansz P, Bae R, Walters D, Clarke A, et al.; Tendyne Global Feasibility Trial Investigators. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol. 2017;69:381-91.
-
- Sorajja P, Moat N, Badhwar V, Walters D, Paone G, Bethea B, et al. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients. J Am Coll Cardiol. 2019;73:1250-60.
-
- Muller DWM, Sorajja P, Duncan A, Bethea B, Dahle G, Grayburn P, et al. 2-Year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation. J Am Coll Cardiol. 2021;78:1847-59.
-
- Wild MG, Kreidel F, Hell MM, Praz F, Mach M, Adam M, et al.; TENDER Investigators. Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experience. Eur J Heart Fail. 2022;24:899-907.
-
- Chhatriwalla AK, Vemulapalli S, Holmes DR Jr, Dai D, Li Z, Ailawadi G, et al. Institutional experience with transcatheter mitral valve repair and clinical outcomes: insights from the TVT registry. JACC Cardiovasc Interv. 2019;12:1342-52.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
